Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-07

Clinical Trial Update: Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Clinical trial update announcing a Phase 2 study of psilocybin-assisted therapy for severe alcohol use disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Brugmann University Hospital | Conditions: Severe Alcohol Use Disorder | Phase 2 | Status: RECRUITING